Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects
Author: Hanna, J.
Foster, D.
Salter, A.
Somogyi, A.
White, J.
Bochner, F.
Citation: British Journal of Clinical Pharmacology, 2005; 60(4):404-413
Publisher: Blackwell Publishing Ltd
Issue Date: 2005
ISSN: 0306-5251
Statement of
Julia Hanna, David J.R. Foster, Amy Salter, Andrew A. Somogyi, Jason M. White and Felix Bochner
Abstract: AIMS: To investigate within- and between-subject variability of the pharmacodynamics and pharmacokinetics of (R)- and (S)-methadone in methadone maintenance subjects at steady-state. METHODS: Six non-holder subjects were studied on three occasions at 7–16 day intervals; doses (20–170 mg/day) remained unchanged. Blood samples and pharmacodynamic data were collected 10–12 times over a 24-h inter-dosing interval. All pharmacodynamic data were expressed as the area under the end-point versus time curve. Using analyses of variance with mixed effects, best estimates were made of the ratio of between- to within-subject variation, with corresponding 95% confidence intervals (CI) for within-subject variation at the average value. RESULTS: Subjects were relatively consistent between occasions, whereas there was much greater between-subject variability (P < 0.02) for all measures. Estimates of the ratio of between- to within-subject variation ranged from 2.2–12.8 for pharmacodynamic measures, and 1.3–7.9 for pharmacokinetic parameters. For pain, total mood disturbance, withdrawal, pupil size and respiration rate, 95% CI for within-subject measures ranged ≤ 2-fold, while this was greater for subjective direct opioid effects (4.2-fold). For CL/F of the active (R)-methadone, the variance ratio was 4.9 (P < 0.0003), with 95% CI for within-subject measures ranging ≤ 2-fold. (S)-methadone CL/F demonstrated greater within-subject variability (3.4-fold), possibly contributing to a smaller (2.7; P < 0.0003) ratio of between- to within-subject variance. CONCLUSIONS: Non-holder methadone maintenance treatment participants appear to respond consistently with respect to pharmacokinetics and pharmacodynamics over a 1–2 month period. Such knowledge may help prescribers to determine whether alternative dosing regimens or treatments might be more appropriate in this population.
Keywords: Pupil; Humans; Opioid-Related Disorders; Substance Withdrawal Syndrome; Methadone; Narcotics; Questionnaires; Area Under Curve; Heart Rate; Adult; Middle Aged; Female; Male
Description: The definitive version is available at
RMID: 0020051050
DOI: 10.1111/j.1365-2125.2005.02464.x
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.